Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03178851
Title Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
HonorHealth Research Institute - Bisgrove Scottsdale Arizona 85258 United States Details
University of Colorado Hospital - Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Baylor University Medical Center Dallas Texas 75231 United States Details
Blacktown Hospital Blacktown New South Wales 2148 Australia Details
Melanoma Institute Australia North Sydney New South Wales 2060 Australia Details
Mid North Coast Cancer Institute Port Macquarie New South Wales 2444 Australia Details
Greenslopes Private Hospital; Clinic Pharmacy Greenslopes Queensland 4120 Australia Details
Flinders Medical Centre Bedford Park South Australia 5042 Australia Details
Peter Maccallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
University Clinical Centre of the Republic of Srpska Banja Luka 78000 Bosnia and Herzegovina Details
University Clinic Ctr Sarajevo Sarajevo 71 000 Bosnia and Herzegovina Details
Instituto de Ensino e Pesquisa Clinica do Ceara Fortaleza CE 60130-241 Brazil Details
Cenantron - Centro Avancado de Tratamento Oncologico Belo Horizonte MG 30130-090 Brazil Details
Instituto Nacional de Cancer - INCa; Oncologia Rio de Janeiro RJ 20560-120 Brazil Details
Hospital Sao Vicente de Paulo Passo Fundo RS 99010-090 Brazil Details
Hospital das Clinicas - UFRGS Porto Alegre RS 90035-903 Brazil Details
Hospital Sao Lucas - PUCRS Porto Alegre RS 90610-000 Brazil Details
Hospital Amaral Carvalho Jau SP 17210-120 Brazil Details
Cape Town Oncology Trials Cape Town 7570 South Africa Details
GVI Constantiaberg Cape Town 7800 South Africa Details
Johese Clinical Research Centurion 1692 South Africa Details
Cancercare George 6529 South Africa Details
Wits Clinical Research; Charlotte Maxeke Johannesburg Academic Hospital Johannesburg 2193 South Africa Details
Cancercare Port Elizabeth 6045 South Africa Details
Steve Biko Academic Hospital; Oncology Pretoria 0002 South Africa Details
Hospital Clinico Universitario de Santiago Santiago de Compostela LA Coruña 15706 Spain Details
Clínica Universidad de Navarra Pamplona Navarra 31620 Spain Details
Hospital Universitario Virgen Macarena Seville Sevilla 41071 Spain Details
Hospital Universitari Quiron Dexeus Barcelona 08028 Spain Details
Hospital Clinic I Provincial Barcelona 08036 Spain Details
MD Anderson Cancer Center Madrid 28033 Spain Details
Hospital Universitario Ramón y Cajal; Pharmacy Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre; Servicio de Oncologia Madrid 28041 Spain Details
Hospital Universitario La Paz; Servicio de Oncologia Madrid 28046 Spain Details
Central Municipal Hospital - Uzhgorod State University Uzhgorod Chernihiv Governorate 88017 Ukraine Details
Public Institution: City Multispecialty Clinical Hospital #4 under Dnipropetrovsk Regional Council Dnipropetrovsk 49102 Ukraine Details
National Cancer Institute MOH of Ukraine Kiev 36022 Ukraine Details
Lviv State Oncology Regional Treatment and Diagnostic Centre Lviv 79031 Ukraine Details
Sumy Regional Clinical Onc Ctr Sumy 40005 Ukraine Details
*Shaded cells indicate that there was no data available from for the field